NCT02166437UNKNOWNanonymous

Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese, Prospective Study

Sponsor

Source record

Tomidahama Hospital

Phase

Source record

Observational

Modality

AI-normalized

monoclonal antibody

Target

AI-normalized

Osteoporosis

Indication / condition

AI-normalized

Osteoporosis

Intervention

Source record

Detailed source ingestion pending.

Related intelligence directories

Indication directory: Osteoporosis Modality directory: monoclonal antibody Target directory: Osteoporosis

Source & freshness

Source record

NCT ID

NCT02166437

Original source

ClinicalTrials.gov

Source last updated

Oct 19, 2016

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT02166437

Title

Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese, Prospective Study

Sponsor

Tomidahama Hospital

Status

UNKNOWN

Phase

Observational

Condition raw

Osteoporosis

Condition normalized

Osteoporosis

Modality raw

Osteoporosis

Modality normalized

monoclonal antibody

Target raw

Osteoporosis

Target normalized

Osteoporosis

Interventions

Detailed source ingestion pending

Public preview

Source record

This clinical trial investigates the efficacy of bisphosphonate and denosumab therapies following teriparatide treatment in Japanese patients with severe osteoporosis. The study aims to analyze bone mineral density (BMD), bone turnover markers, and fracture prevention effects in a cohort of 500 patients.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Early access offer

Subscribe with code FOUNDERS5 for a 5-day premium trial.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

Investment-Ready Snapshot

Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese, Prospective Study

Source & freshness

Public preview

Create an account to unlock this report

Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese, Prospective Study

Investment-Ready Snapshot

Provenance

Protocol Description

Outcome Measures

Eligibility

Known Results And Readout Context

Patent And IP Landscape

Contacts